Drug–device combination products are becoming increasingly prevalent, with many lasting years beyond the expiration date of primary and secondary patents on the drug itself. It is unknown how common ...

Combination products, i.e., those containing any combination of a drug, device, or biological, constitute a growing category of innovative medical products. Examples include a drug with an implantable ...

Enable Injections debuts the first multi-vial/multi syringe system for biologics delivery. The small, handheld device can also be used for variable dosing based on patient’s weight, providing maximum ...

While the concept of a combination product is not new, these unique healthcare products (drug plus device, biological plus device, drug plus biological product, or drug plus device plus biological ...

The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of approximately 9% during the forecast period. This growth is largely driven by the ...

WINDSOR, Connecticut, Aug. 6 (TNSRes) -- LIMRA issued the following news release: After strong results in 2019, total new premium for individual life combination products decreased 23% to $3.7 billion ...